Robert Lionberger, Ph.D., Director of the Office of Research and Standards in the Office of Generic Drugs (OGD) at the FDA describes regulatory science initiatives of OGD and unmet needs for generic drugs.
Published 2015-06-09 · Watch on YouTube ↗ Availability and playback restrictions are controlled by the original channel.